Moderna Again Faces Claims It Excluded Others’ Work In Developing COVID-19 Vaccine

 
• By Brenda Sandburg
  
Lipid nanoparticles
Arbutus claims Moderna used its patented lipid nanoparticle technology to develop Spikevax • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet